CD79A and nasopharyngeal carcinoma: Similar to earlier findings showing higher positivity rate of EBV DNA than serum VCA-IgA antibody in NPC patients [11, 12, 32], higher positivity rate was observed for EBV DNA (61.4%) than VCA-IgA (41.1%) and EA-IgA (18.4%) in ENKTCL patients.